🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Safety and Feasibility of a Self-Balancing Exoskeleton for Rehabilitation in the Thoracic Surgical Intensive Care Unit: a Pilot Trial

RecruitingPhase 1, Phase 2Ages 18 Years - anyAllWandercraft
NCT07220733 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Patients admitted to the Intensive Care Unit (ICU) after thoracic surgery often experience complications related to immobility, such as muscle weakness, pulmonary issues, and longer recovery times. Early mobilization has been shown to improve outcomes, but its implementation is often limited by patient fragility and staff resources. This study will test the safety and feasibility of using the Atalante X, a self-balancing exoskeleton, in the Thoracic Surgical ICU at Brigham and Women's Hospital. The exoskeleton is designed to support patients in standing and walking, even if they have limited strength or balance, thereby reducing the physical burden on healthcare staff and increasing patient mobility. Eligible participants are adults recovering from thoracic surgery, who are debilitated (Johns Hopkins Highest Level of Mobility scale ≤ 5). Each participant will undergo up to 2-3 exoskele

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Above age of 18 years old, * Having undergone thoracic surgery that necessitated admission in the TSICU. * Debilitated as defined as a JH-HLM score of 5 or less Exclusion Criteria: * Height \< 6'3 feet or weight \> 220 lbs restrictions * Severe muscular spasticity of the lower extremities (Modified Ashworth Scale Grade 3 higher). * Current fractures or incomplete bone junctions in the spine, pelvis, and/or lower extremities * Osteoporosis or lower bone mineral density -3.5, and history(ies) of osteoporotic fracture(s). * Skin disorders including Stage I pressure injuries at the hip, lower limbs, and Exoskeleton contact areas, according to the National and European Pressure Ulcer Classification System (NPUAP-EPUAP). * Severe arthritis, acute arthritis, or synovitis after total or partial lower limb joint replacement. * Myocardial infarction or angina or ischemic heart disease within the last 6 months. * Uncorrectable leg length discrepancy over 2 cm when using additional correction tools. * III-IV spine scoliotic deformity. * Amputations and lower limb prostheses. * Pregnancy * Adults who lack the capacity to provide informed consent * Cardiovascular instability as indicated by: * Presence of unstable ventricular or atrial arrhythmias * HR \< 40 or HR \> 140 * Lactate \> 4.0 mmol/L * On moderate-high dose vasopressors/inotropes * Currently on VA ECMO * Respiratory instability as indicated by: * FiO2 \> 0.6 * PEEP \> 12 cm H2O * RR \> 35 bpm * Currently on VV-ECMO * Unable to follow commands * Has bed rest orders
💊

What it tests

  • Self-balancing robotic exoskeleton (Atalante X)
📍

Where

1 site
Brigham and Women's Hospital
Boston, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy